Absci (ABSI) vs NRC Health (NRC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Absci (ABSI) has outperformed NRC Health (NRC) over the past year, gaining 113.9% versus a gain of 71.3%. Over five years, ABSI leads with a -15.9% price change compared with -52.4% for NRC. Absci is the larger company by market cap ($1.74 billion vs $449.7 million), about 3.9 times the size.
NRC Health pays a dividend yielding 2.95%, while Absci does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABSI | NRC |
|---|---|---|
| Share price | $10.16 | $20.33 |
| Market cap | $1.74B | $449.69M |
| 1-day change | +13.65% | -0.44% |
| YTD return | +156.16% | +8.79% |
| 1-year return | +113.88% | +71.31% |
| 5-year return | -15.90% | -52.38% |
| P/E ratio (TTM) | — | 84.71 |
| Forward P/E | — | 19.36 |
| EPS (TTM) | $-0.79 | $0.24 |
| Dividend yield | 0.00% | 2.95% |
| Annual dividend | $0.00 | $0.60 |
| Revenue (latest FY) | $2.80M | — |
| Revenue growth (YoY) | -38.24% | — |
| Net income (latest FY) | $-115.18M | — |
| Operating margin | -4297.04% | — |
| Net margin | -4113.68% | — |
| 52-week high | $12.06 | $23.68 |
| 52-week low | $2.24 | $11.01 |
| Distance from 52-week high | -15.72% | -14.15% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +41.73% | +27.89% |
| Average volume | 3.45M | 115.97K |
| Shares outstanding | 171.61M | 22.12M |
| Employees | 140 | 357 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Absci is about 3.9 times larger than NRC Health by market value ($1.74B vs $449.69M).
- ABSI has outperformed NRC by 42.6 percentage points over the past year.
- NRC Health offers a meaningfully higher dividend yield (2.95% vs 0.00%).
About Absci
ABSI stock →Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 140 employees
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
ABSI vs NRC FAQ
Which is bigger, Absci or NRC Health?
Absci (ABSI) is larger, with a market capitalization of $1.74B compared with $449.69M for NRC Health (NRC).
Which stock has performed better over the past year, ABSI or NRC?
ABSI returned +113.88% over the past 12 months, compared with +71.31% for NRC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Absci or NRC Health?
NRC Health pays a dividend yielding 2.95%, while Absci does not currently pay a regular dividend.
Are Absci and NRC Health in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.